PROTECTIVE ROLE OF CARNITINE SYNERGIZED WITH VITAMIN E AGAINST ISOPROTERENOL INDUCED CARDIAC INFARCTION IN RATS
The current study aimed to evaluate the role of carnitine in combination with vitamin E in protection against myocardial infarction induced by isoproterenol (ISO) in rats. Rats were grouped into 5 (each 10 rats): Group I. Control fed a standard diet. Group III: Rats were injected with vitamin E (100...
Saved in:
Published in | African journal of traditional, complementary, and alternative medicines Vol. 14; no. 2; pp. 25 - 32 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Nigeria
African Traditional Herbal Medicine Supporters Initiative (ATHMSI)
2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The current study aimed to evaluate the role of carnitine in combination with vitamin E in protection against myocardial infarction induced by isoproterenol (ISO) in rats.
Rats were grouped into 5 (each 10 rats): Group I. Control fed a standard diet. Group III: Rats were injected with vitamin E (100 IU/kg bw, i.p) daily. Group IV: Rats were given carnitine (20 mg/kg bw, i.p) daily. Group V: Rats were injected with both vitamin E (100 IU/kg bw,
and carnitine (20 mg/kg bw,
daily. On 7
, 8
, and 9
day, rats in groups (II-V) were injection
with ISO (55mg/kg b.w for successive three days). The treatment with carnitine and vitamin E were continuous for 21 days.
Canirine combined with vitamin E significantly increased coronary flow (CF) (P<0.001) in rats injected with ISO. The recovery of rate pressure product (RPP) and left ventricular developed pressure (LVDP) were significantly improved in treated rats in comparison to untreated. The rats administrated with ISO resulted in a significant elevation of serum enzymes (CK-MB and LDH) compared with control group (p<0.001). However, it returned to about normal. ISO administration resulted in a significant elevation in the levels of malondialdehyde (MDA) and nitric oxide (NO) as compared with control (p<0.001) and a significant reduction in the activities of GSPxase and GSRase (p<0.001) compared with control group. The levels of cardiac inflammatory markers interleukine-6 (IL-6) and tumor necrosis factor (TNF-α) were markedly elevated in rats injected with ISO compared with control group. Vitamin E combined with carnitine reversed these effects. However, pretreatment with vitamin E or carnitine or combined together showed a significant reduction in MDA and NO (p<0.001) and a significant elevation in the activities of GSPxase and GSRase (p<0.001) as compared to ISO injected group. The combined effect was more significant than individual ones.
Vitamin E combined with carnitine exerts potential protective effect against MI through suppression of inflammatory mediators and enhancement of antioxidant activity. |
---|---|
AbstractList | Background: The current study aimed to evaluate the role of carnitine in combination with vitamin E in protection
against myocardial infarction induced by isoproterenol (ISO) in rats.
Materials and Methods: Rats were grouped into 5 (each 10 rats): Group I. Control fed a standard diet. Group III: Rats
were injected with vitamin E (100 IU/kg bw, i.p) daily. Group IV: Rats were given carnitine (20 mg/kg bw, i.p) daily
.Group V: Rats were injected with both vitamin E (100 IU/kg bw, i.p) and carnitine (20 mg/kg bw, i.p) daily. On 7th,
8th, and 9th day, rats in groups (II-V) were injection i.p with ISO (55mg/kg b.w for successive three days). The
treatment with carnitine and vitamin E were continuous for 21 days.
Results: Canirine combined with vitamin E significantly increased coronary flow (CF) (P BACKGROUNDThe current study aimed to evaluate the role of carnitine in combination with vitamin E in protection against myocardial infarction induced by isoproterenol (ISO) in rats.MATERIALS AND METHODSRats were grouped into 5 (each 10 rats): Group I. Control fed a standard diet. Group III: Rats were injected with vitamin E (100 IU/kg bw, i.p) daily. Group IV: Rats were given carnitine (20 mg/kg bw, i.p) daily. Group V: Rats were injected with both vitamin E (100 IU/kg bw, i.p) and carnitine (20 mg/kg bw, i.p) daily. On 7th, 8th, and 9th day, rats in groups (II-V) were injection i.p with ISO (55mg/kg b.w for successive three days). The treatment with carnitine and vitamin E were continuous for 21 days.RESULTSCanirine combined with vitamin E significantly increased coronary flow (CF) (P<0.001) in rats injected with ISO. The recovery of rate pressure product (RPP) and left ventricular developed pressure (LVDP) were significantly improved in treated rats in comparison to untreated. The rats administrated with ISO resulted in a significant elevation of serum enzymes (CK-MB and LDH) compared with control group (p<0.001). However, it returned to about normal. ISO administration resulted in a significant elevation in the levels of malondialdehyde (MDA) and nitric oxide (NO) as compared with control (p<0.001) and a significant reduction in the activities of GSPxase and GSRase (p<0.001) compared with control group. The levels of cardiac inflammatory markers interleukine-6 (IL-6) and tumor necrosis factor (TNF-α) were markedly elevated in rats injected with ISO compared with control group. Vitamin E combined with carnitine reversed these effects. However, pretreatment with vitamin E or carnitine or combined together showed a significant reduction in MDA and NO (p<0.001) and a significant elevation in the activities of GSPxase and GSRase (p<0.001) as compared to ISO injected group. The combined effect was more significant than individual ones.CONCLUSIONVitamin E combined with carnitine exerts potential protective effect against MI through suppression of inflammatory mediators and enhancement of antioxidant activity. The current study aimed to evaluate the role of carnitine in combination with vitamin E in protection against myocardial infarction induced by isoproterenol (ISO) in rats. Rats were grouped into 5 (each 10 rats): Group I. Control fed a standard diet. Group III: Rats were injected with vitamin E (100 IU/kg bw, i.p) daily. Group IV: Rats were given carnitine (20 mg/kg bw, i.p) daily. Group V: Rats were injected with both vitamin E (100 IU/kg bw, and carnitine (20 mg/kg bw, daily. On 7 , 8 , and 9 day, rats in groups (II-V) were injection with ISO (55mg/kg b.w for successive three days). The treatment with carnitine and vitamin E were continuous for 21 days. Canirine combined with vitamin E significantly increased coronary flow (CF) (P<0.001) in rats injected with ISO. The recovery of rate pressure product (RPP) and left ventricular developed pressure (LVDP) were significantly improved in treated rats in comparison to untreated. The rats administrated with ISO resulted in a significant elevation of serum enzymes (CK-MB and LDH) compared with control group (p<0.001). However, it returned to about normal. ISO administration resulted in a significant elevation in the levels of malondialdehyde (MDA) and nitric oxide (NO) as compared with control (p<0.001) and a significant reduction in the activities of GSPxase and GSRase (p<0.001) compared with control group. The levels of cardiac inflammatory markers interleukine-6 (IL-6) and tumor necrosis factor (TNF-α) were markedly elevated in rats injected with ISO compared with control group. Vitamin E combined with carnitine reversed these effects. However, pretreatment with vitamin E or carnitine or combined together showed a significant reduction in MDA and NO (p<0.001) and a significant elevation in the activities of GSPxase and GSRase (p<0.001) as compared to ISO injected group. The combined effect was more significant than individual ones. Vitamin E combined with carnitine exerts potential protective effect against MI through suppression of inflammatory mediators and enhancement of antioxidant activity. |
Author | Huwait, Etimad A Al-Ghamdi, Maryam A |
AuthorAffiliation | 3 Vitamin D Pharmacogenomics Research Group, King Abdulaziz University, Jeddah, Saudi Arabia 2 Experimental biochemistry unit, King Fahad Medical Research center (KFMRC), King Abdulaziz University, Saudi Arabia 1 Biochemistry Department, Faculty of science, King Abdulaziz University, Saudi Arabia |
AuthorAffiliation_xml | – name: 1 Biochemistry Department, Faculty of science, King Abdulaziz University, Saudi Arabia – name: 2 Experimental biochemistry unit, King Fahad Medical Research center (KFMRC), King Abdulaziz University, Saudi Arabia – name: 3 Vitamin D Pharmacogenomics Research Group, King Abdulaziz University, Jeddah, Saudi Arabia |
Author_xml | – sequence: 1 givenname: Etimad A surname: Huwait fullname: Huwait, Etimad A organization: Experimental biochemistry unit, King Fahad Medical Research center (KFMRC), King Abdulaziz University, Saudi Arabia – sequence: 2 givenname: Maryam A surname: Al-Ghamdi fullname: Al-Ghamdi, Maryam A organization: Experimental biochemistry unit, King Fahad Medical Research center (KFMRC), King Abdulaziz University, Saudi Arabia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28573219$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkUlPwzAQhS0EgrKcuSEfuaS1HWfxBSlK3dZSSVAaQHCxHMeBVG0CSVuJf0-6gODi8WjefDOadw6Oq7oyAFxj1CcYYTRQ85VWy_4G05L06RHoEQc5FkKUHoMewj6zXITdM3DetnOEbB8T7xScEd_xbIJZD9QPSZzyMBVPHCbxlMN4BMMgiUQqIg5nLxFPxuKVD-GzSCfwSaTBvYggh8E4ENEshWIW7wgJj-IpFNHwMezEHWEogrDLR0HSweOo-8IkSGeX4KRQi9ZcHeIFeBzxNJxY03gswmBqaeJ6KytnnqFG267KGHM0VcZXfu5iU-g8sz3CMCW2Mq6bkbzIKNI5wiZ3soJ6xmeM2hfgbs_9WGdLk2tTrRq1kB9NuVTNl6xVKf9XqvJdvtUb6VDqUgd1gNsDoKk_16ZdyWXZarNYqMrU61Zihrobds921mAv1U3dto0pfsdgJHc2yb1NcmeT3Hbc_N3uV__ji_0NfdWKpg |
CitedBy_id | crossref_primary_10_1016_j_heliyon_2024_e25057 crossref_primary_10_5812_ijhrba_84212 crossref_primary_10_37349_emed_2021_00070 crossref_primary_10_1016_j_biopha_2021_112139 crossref_primary_10_2174_1389557519666190130164334 |
ContentType | Journal Article |
Copyright | Copyright: © 2017 Afr. J. Traditional Complementary and Alternative Medicines 2017 |
Copyright_xml | – notice: Copyright: © 2017 Afr. J. Traditional Complementary and Alternative Medicines 2017 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
DOI | 10.21010/ajtcam.v14i2.4 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2505-0044 |
EndPage | 32 |
ExternalDocumentID | 10_21010_ajtcam_v14i2_4 28573219 |
Genre | Journal Article |
GroupedDBID | --- 23M 2WC 4JU 53G 5GY AAFWJ ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CGR CUY CVF DIK E3Z EBS ECM EIF EJD GX1 HYE KWQ NPM OK1 P2P P6G RBI RPM TR2 XSB AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c267t-d97e4ec36ab995c4ae8a8d61efcdb37291423ae66b2dfb40cd01ed5bf47e89943 |
IEDL.DBID | RPM |
ISSN | 0189-6016 |
IngestDate | Fri Sep 01 02:34:03 EDT 2023 Thu Apr 11 18:15:12 EDT 2024 Fri Aug 23 00:38:24 EDT 2024 Thu Nov 24 22:18:12 EST 2022 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Myocardial infarction Vitamin E-carnitine ISO |
Language | English |
License | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c267t-d97e4ec36ab995c4ae8a8d61efcdb37291423ae66b2dfb40cd01ed5bf47e89943 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446450/ |
PMID | 28573219 |
PQID | 1905739054 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5446450 proquest_miscellaneous_1905739054 crossref_primary_10_21010_ajtcam_v14i2_4 pubmed_primary_28573219 |
PublicationCentury | 2000 |
PublicationDate | 2017-00-00 |
PublicationDateYYYYMMDD | 2017-01-01 |
PublicationDate_xml | – year: 2017 text: 2017-00-00 |
PublicationDecade | 2010 |
PublicationPlace | Nigeria |
PublicationPlace_xml | – name: Nigeria |
PublicationTitle | African journal of traditional, complementary, and alternative medicines |
PublicationTitleAlternate | Afr J Tradit Complement Altern Med |
PublicationYear | 2017 |
Publisher | African Traditional Herbal Medicine Supporters Initiative (ATHMSI) |
Publisher_xml | – name: African Traditional Herbal Medicine Supporters Initiative (ATHMSI) |
References | 1464372 - FASEB J. 1992 Dec;6(15):3379-86 11802770 - Biochem J. 2002 Feb 1;361(Pt 3):417-29 16106184 - Cardiol Rev. 2005 Sep-Oct;13(5):231-9 8800132 - J Am Coll Cardiol. 1996 Aug;28(2):506-14 6066618 - J Lab Clin Med. 1967 Jul;70(1):158-69 20685679 - Eur Heart J. 2010 Sep;31(18):2197-204 15086477 - Kidney Int. 2004 Apr;65(4):1375-80 26786992 - Acta Med Iran. 2015 Nov;53(11):703-10 26281314 - Turk J Med Sci. 2015;45(3):517-25 23406956 - Toxicol Ind Health. 2015 May;31(5):467-74 15591001 - Ann N Y Acad Sci. 2004 Nov;1033:30-41 8752197 - Am J Cardiol. 1996 Aug 15;78(4):477-9 10639540 - N Engl J Med. 2000 Jan 20;342(3):154-60 4436300 - J Biol Chem. 1974 Nov 25;249(22):7130-9 2756917 - Am J Clin Nutr. 1989 Aug;50(2):301-6 12401733 - Diabetes Care. 2002 Nov;25(11):1919-27 6123712 - Lancet. 1982 Jun 19;1(8286):1419-20 760819 - Biochim Biophys Acta. 1979 Jan 4;582(1):67-78 1678029 - Lancet. 1991 Apr 20;337(8747):933-5 2007906 - J Nutr. 1991 Apr;121(4):539-46 18203961 - Nutr Clin Pract. 2008 Feb;23(1):16-34 3532087 - Prev Med. 1986 Jul;15(4):373-90 |
References_xml | |
SSID | ssj0038127 |
Score | 2.1514022 |
Snippet | The current study aimed to evaluate the role of carnitine in combination with vitamin E in protection against myocardial infarction induced by isoproterenol... Background: The current study aimed to evaluate the role of carnitine in combination with vitamin E in protection against myocardial infarction induced by... BACKGROUNDThe current study aimed to evaluate the role of carnitine in combination with vitamin E in protection against myocardial infarction induced by... |
SourceID | pubmedcentral proquest crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 25 |
SubjectTerms | Animals Anti-Inflammatory Agents - pharmacology Anti-Inflammatory Agents - therapeutic use Antioxidants - metabolism Antioxidants - pharmacology Antioxidants - therapeutic use Cardiotonic Agents - adverse effects Cardiotonic Agents - therapeutic use Carnitine - pharmacology Carnitine - therapeutic use Glutathione Peroxidase - metabolism Glutathione Reductase - metabolism Heart - drug effects Inflammation - blood Inflammation - etiology Inflammation - prevention & control Isoproterenol - adverse effects Male Malondialdehyde - blood Myocardial Infarction - chemically induced Myocardial Infarction - metabolism Myocardial Infarction - pathology Myocardial Infarction - prevention & control Myocardium - metabolism Myocardium - pathology Nitric Oxide - blood Oxidative Stress - drug effects Rats Vitamin E - pharmacology Vitamin E - therapeutic use |
Title | PROTECTIVE ROLE OF CARNITINE SYNERGIZED WITH VITAMIN E AGAINST ISOPROTERENOL INDUCED CARDIAC INFARCTION IN RATS |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28573219 https://search.proquest.com/docview/1905739054 https://pubmed.ncbi.nlm.nih.gov/PMC5446450 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db5swELfaPkx7mfa97EuetIe9kACxwTwi4jSeGqgI6bq9IGMbNdNCqi3d37-zCVW7ve0FgWwsdL8Td-c7_w6hj7ZHkQ5I4MXMVx5JWOQlMW09o8G4xSyKEmLPDi_zaLEmny_p5RGiw1kYV7Svms24-7Edd5srV1t5vVWToU5scr7MKLH5OH9yjI5BQYcQvf_9ggXq-7QGLPEs10jP5wORTeBP5Pe9ktvx74BswrFtyRMyGk9DS7Nz1yr942r-XTF5xwTNH6NHB98Rp_03PkFHpnuKHiwP2fFnaHdeFhXPKnHBcVmccVzMcZaWuahEzvHqa87LU_GNz_AXUS3whajSpcgxx-lpCjF8hcWqcCuUPC_OsMhn6wwmwwozkWbwPE9LV3ICt7hMq9VztJ7zKlt4h4YKngqjeO_pJDbEqGkkmyShikjDJNNRYFqlG5u_C8C5kiaKmlC3DfGV9gOjadOS2EBcRqYv0Em368wrhMHNSmDIp37rExlS2epWMpC-tNTlLB6hT4NA6-ueN6OGeMPBUPcw1A6GmozQh0HgNei2TVjIzuxuftXgrAA8cIE5L3sAbhcbkBuh-B40txMsb_b9EVAnx599UJ_X__3mG_QwtNbd7cS8RSf7nzfmHfgm--a908U_yzDcJA |
link.rule.ids | 230,315,730,783,787,888,4031,27935,27936,27937,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb5swFLa6Ttp2Wfe7WdvNk3bYBQLE_DoiQhpvASriZO0uyBijZltItZEd9tfvGULVdqftgkA2Fuized_jPX8PofeqRlFpElNzPUNoxPcczXftSpMlGDfXcxyfqL3DceJMF-TjuX2-h-x-L0ybtC-KlV5_X-v16rLNrbxai2GfJzY8i0ObqHicMbyH7sN6NUjvpHcfYLBBXaVW0_M1pTbSKfqAb2MaQ_61EXyt_zLJytJVUR7Ls92RpYR2btqlv8jm3ZzJG0ZocoCW_eN3uSff9G1T6OL3HWXHf36_J-jxjpbioGt-ivZk_Qw9iHeB9-doc5alLAoZXUY4S2cRTic4DLKEMppEeH6RRNkp_RKN8WfKpnhJWRDTBEc4OA1oMmeYztN2hCxK0hmmyXgRQmcYYUyDEK4nQdZms8ApzgI2f4EWk4iFU21Xq0ETluM2Wum7kkgxcnjh-7YgXHrcKx1TVqIsVGjQBN7GpeMUVlkVxBClYcrSLiriSnD5yOgl2q83tTxEGBicD02GbVQG4ZbNq7LiHsDKlSq65w7Qhx6p_KqT5MjBlWnxzTt88xbfnAzQux7JHJaNioXwWm62P3PgQYA7HKDPqw7Z68H6KTFA7i3MrzsoSe7bLYBkK829Q-71f9_5Fj2csniWz2jy6Qg9shSJaH_4HKP95sdWngAFaoo37YT_AyxX_hY |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj5swELbarbTqpe9H-nSlHnqBADGvIyKwcZtARMh2dy_I2EbNbkOilvTQX98xhFV2e9sLAnmwZH2G-YYZvkHos-pRJExiaq5ncI34nqP5rl1pUoBzcz3H8Yn6d3iWOJMl-Xpmnx20-mqL9nm50uufa71e_WhrK7drPuzrxIbzWWgTlY8zhltRDe-jB_DMGk4fqHcvYfBDXbdW0_M1pTjSqfpAfGMaQ3bZcLbW_5hkZemqMY_l2e7IUmI7h77pP8J5u27ywBHFj9FFv4Su_uRK3zWlzv_eUne80xqfoEd7eoqDzuQpuifrZ-h4tk_AP0ebeZbmUZjT0whn6TTCaYzDIEtoTpMIL86TKDuhF9EYf6f5BJ_SPJjRBEc4OAlossgxXaTtDFmUpFNMk_EyBGOYYUyDEK7jIGurWuAUZ0G-eIGWcZSHE23fs0HjluM2mvBdSSQfOaz0fZsTJj3mCceUFRelShGawN-YdJzSElVJDC4MUwq7rIgrIfQjo5foqN7U8jXCwOR8GDJsozIIs2xWiYp5AC1T6uieO0BferSKbSfNUUBI02JcdBgXLcYFGaBPPZoFPD4qJ8Jqudn9LoAPAfZwAJtXHbrXk_XbYoDcG7hfGyhp7psjgGYr0b1H782d7_yIjufjuJjS5Ntb9NBSXKL97vMOHTW_dvI9MKGm_NDu-X9uPQCl |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PROTECTIVE+ROLE+OF+CARNITINE+SYNERGIZED+WITH+VITAMIN+E+AGAINST+ISOPROTERENOL+INDUCED+CARDIAC+INFARCTION+IN+RATS&rft.jtitle=African+journal+of+traditional%2C+complementary%2C+and+alternative+medicines&rft.au=Huwait%2C+Etimad+A.&rft.au=Al-Ghamdi%2C+Maryam+A.&rft.date=2017&rft.issn=0189-6016&rft.eissn=2505-0044&rft.volume=14&rft.issue=2&rft.spage=25&rft.epage=32&rft_id=info:doi/10.21010%2Fajtcam.v14i2.4&rft.externalDBID=n%2Fa&rft.externalDocID=10_21010_ajtcam_v14i2_4 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0189-6016&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0189-6016&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0189-6016&client=summon |